ExCEEd Orphan announces a further consulting cooperation with Akcea Therapeutics in the CEE
AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for
Akcea and Ionis Announce the approval of WAYLIVRA® (volanesorsen) in the European Union.
ExCEEd Orphan announces its cooperation with AveXis (https://www.avexis.com/) in relation to the Spinal
ExCEEd Orphan announces a consulting cooperation with Akcea Therapeutics (https://akceatx.com/) in the CEE
The consulting company ExCEEd Orphan s.r.o. was established on August 29 in Prague,